Quelle est la signification des anomalies observées en scintigraphie osseuse ?

Watanabe, 1991, Comparison of MRI, CT and bone scintigraphy in metastases of experimental neoplasm, Tohoku J Exp Med, 163, 229, 10.1620/tjem.163.229

Rodan, 1996, Bisphosphonates: mechanisms of action, J Clin Invest, 97, 2692, 10.1172/JCI118722

Schwartz, 1993, Uptake and biodistribution of technetium-99m-MD32P during rat tibial bone repair, J Nucl Med, 34, 104

Goltzman, 2001, Osteolysis and cancer, J Clin Invest, 107, 1219, 10.1172/JCI13073

Yin, 2005, Mechanisms of cancer metastasis to the bone, Cell Res, 15, 57, 10.1038/sj.cr.7290266

Matsumoto, 2006, Bone destruction in multiple myeloma, Ann N Y Acad Sci, 1068, 319, 10.1196/annals.1346.035

Gligorov, 2000, Bisphosphonates et cancer : mécanismes d’action et indications cliniques dans l’ostéolyse maligne, Lett Cancérol, 9, 36

Comet, 1998, Radiopharmaceutiques à tropisme osseux, 485

Watt, 1981, Effects of acute administration of ethane hydroxydiphosphonate (EHDP) on skeletal scintigraphy with technetium-99m methylene diphosphonic acid (Tc-MDP) in the rat, Brit J Radiol, 54, 592, 10.1259/0007-1285-54-643-592

Paycha, 2002, Impact des bisphosphonates thérapeutiques sur la scintigraphie osseuse aux bisphosphonates radiomarqués, Oncoscopie, 8, 14

Paycha F, Richard B. Exploration scintigraphique du squelette. Encycl Méd Chir (Éditions Scientifiques et Médicales Elsevier SAS, Paris), Radiodiagnostic-Squelette normal, 30-480-A-10, 2001, 37 p.

Decroisette, 2006, Le traitement des métastases osseuses par les biphosphonates, Méd Nucl, 30, 164

Guillemart, 1990, Bone kinetics of calcium-45 and pyrophosphate labeled with technetium-96: an autoradiographic evaluation, J Nucl Med, 31, 466

Kaye, 1975, Technetium-99m-pyrophosphate: studies in vivo and in vitro, J Nucl Med, 16, 40

Einhorn, 1986, Localization of technetium-99m methylene diphosphonate in bone using microautoradiography, J Orthop Res, 4, 180, 10.1002/jor.1100040206

Toegel, 2006, Uptake of bone-seekers is solely associated with mineralization. A study with 99mTc-MDP, 153Sm-EDTMP and 18F-fluoride on osteoblasts, Eur J Nucl Med Mol Imaging, 33, 491, 10.1007/s00259-005-0026-x

Loutfi, 2003, Nonosseous abnormalities on bone scans, J Nucl Med Technol, 31, 149

Boissier, 1997, Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices, Cancer Res, 57, 3890

Passeri, 1995, The effect of bisphosphonates on the secretion of IL6 by the MG-63 osteoblastic cell line and the formation of CFU-F and CFU-OB in murine bone marrow, Bone, 16, 169

Rogers, 2004, From molds and macrophages to mevalonate: a decade of progress in understanding the molecular mode of action of bisphosphonates, Calcif Tissue Int, 75, 451, 10.1007/s00223-004-0024-1

Sahni, 1993, Bisphosphonates act on rat bone resorption through the mediation of osteoblasts, J Clin Invest, 91, 2004, 10.1172/JCI116422

Shipman, 1997, Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumor activity, Br J Haematol, 98, 665, 10.1046/j.1365-2141.1997.2713086.x

Salgia, 1994, Changes in Tc-99m radionuclide bone scan images and peripheralization of marrow hematopoietic activity associated with the administration of granulocyte colony stimulating factor as an adjunct to dose-intensified chemotherapy for breast cancer, Cancer, 74, 1887, 10.1002/1097-0142(19941001)74:7<1887::AID-CNCR2820740710>3.0.CO;2-6

Boyle, 2003, Osteoclast differentiation and activation, Nature, 423, 337, 10.1038/nature01658

Hirbe, 2007, Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner, Blood, 109, 3424, 10.1182/blood-2006-09-048686

Joshua, 2003, Bisphosphonates resistance in Paget's disease of bone, Arthritis Rheum, 48, 2321, 10.1002/art.11136

Cohen, 2006, The new bone biology: pathologic, molecular and clinical correlates, Am J Med Genet Part A, 140, 2646, 10.1002/ajmg.a.31368

Terpstra, 2002, Bone mineralization in polyostotic fibrous dysplasia: histomorphometric analysis, J Bone Miner Res, 17, 1949, 10.1359/jbmr.2002.17.11.1949

Riminucci, 2006, Fibrous dysplasia as a stem cell disease, J Bone Miner Res, 21, P125, 10.1359/jbmr.06s224

Kransdorf, 1990, Fibrous dysplasia, Radiographics, 10, 519, 10.1148/radiographics.10.3.2188311

Machida, 1986, Scintigraphic manifestation of fibrous dysplasia, Clin Nucl Med, 11, 426, 10.1097/00003072-198606000-00015